193 related articles for article (PubMed ID: 33883739)
1. Africa's vaccines revolution must have research at its core.
Nature; 2021 Apr; 592(7855):487-488. PubMed ID: 33883739
[No Abstract] [Full Text] [Related]
2. COVID vaccines to reach poorest countries in 2023 - despite recent pledges.
Padma TV
Nature; 2021 Jul; 595(7867):342-343. PubMed ID: 34226742
[No Abstract] [Full Text] [Related]
3. It's time to consider a patent reprieve for COVID vaccines.
Nature; 2021 Apr; 592(7852):7. PubMed ID: 33785920
[No Abstract] [Full Text] [Related]
4. Why a pioneering plan to distribute COVID vaccines equitably must succeed.
Nature; 2021 Jan; 589(7841):170. PubMed ID: 33442047
[No Abstract] [Full Text] [Related]
5. The fight to manufacture COVID vaccines in lower-income countries.
Maxmen A
Nature; 2021 Sep; 597(7877):455-457. PubMed ID: 34526695
[No Abstract] [Full Text] [Related]
6. Challenges in the rollout of COVID-19 vaccines worldwide.
Burki TK
Lancet Respir Med; 2021 Apr; 9(4):e42-e43. PubMed ID: 33684355
[No Abstract] [Full Text] [Related]
7. Chelsea Clinton urges global sharing of COVID vaccine technology.
Maxmen A
Nature; 2021 Aug; 596(7872):331. PubMed ID: 34376853
[No Abstract] [Full Text] [Related]
8. Just allocation of COVID-19 vaccines.
Herlitz A; Lederman Z; Miller J; Fleurbaey M; Venkatapuram S; Atuire C; Eckenwiler L; Hassoun N
BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33589419
[No Abstract] [Full Text] [Related]
9. Public-private partnerships boost research on neglected diseases.
Louët S
Nat Biotechnol; 2003 Nov; 21(11):1254-5. PubMed ID: 14595339
[No Abstract] [Full Text] [Related]
10. World Bank grants for global vaccination - why so slow?
Sandefur J
Nature; 2021 Jun; 594(7864):475. PubMed ID: 34158648
[No Abstract] [Full Text] [Related]
11. Africa's leadership in biomedical research: Shifting the center of gravity.
Kay S
Sci Transl Med; 2015 Nov; 7(314):314ed13. PubMed ID: 26582894
[No Abstract] [Full Text] [Related]
12. Why some researchers oppose unrestricted sharing of coronavirus genome data.
Maxmen A
Nature; 2021 May; 593(7858):176-177. PubMed ID: 33953391
[No Abstract] [Full Text] [Related]
13. A patent waiver on COVID vaccines is right and fair.
Nature; 2021 May; 593(7860):478. PubMed ID: 34035532
[No Abstract] [Full Text] [Related]
14. Cash payments in Africa could boost vaccine uptake.
Arezki R
Nature; 2021 Aug; 596(7870):9. PubMed ID: 34345045
[No Abstract] [Full Text] [Related]
15. Vaccine venture boosts health hopes.
Butler D
Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588
[No Abstract] [Full Text] [Related]
16. Africa's need for more COVID-19 clinical trials.
Makoni M
Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
[No Abstract] [Full Text] [Related]
17. Balancing options for health research and development.
Love J
Bull World Health Organ; 2012 Nov; 90(11):796-796A. PubMed ID: 23226887
[No Abstract] [Full Text] [Related]
18. Coordinating COVID-19 vaccine deployment through the WHO COVID-19 Partners Platform.
Yu MA; Shen AK; Ryan MJ; Boulanger LL
Bull World Health Organ; 2021 Mar; 99(3):171-171A. PubMed ID: 33716336
[No Abstract] [Full Text] [Related]
19. WHO expectation and industry goals.
Vandersmissen W
Vaccine; 2001 Feb; 19(13-14):1611-5. PubMed ID: 11166883
[TBL] [Abstract][Full Text] [Related]
20. Omicron is bad but the global response is worse.
Nature; 2021 Dec; 600(7888):190. PubMed ID: 34876667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
